0001698998-24-000001.txt : 20240311
0001698998-24-000001.hdr.sgml : 20240311
20240311163534
ACCESSION NUMBER: 0001698998-24-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woolson Daniel
CENTRAL INDEX KEY: 0001698998
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 24738592
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC., 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-03-07
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001698998
Woolson Daniel
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
VP, GM-Infusion Capital
0
Common Stock
2024-03-07
4
M
0
966
0.0
A
10843
D
Common Stock
2024-03-07
4
F
0
426
105.39
D
10417
D
Common Stock
2024-03-07
4
M
0
5792
0.0
A
16209
D
Common Stock
2024-03-07
4
F
0
2564
105.39
D
13645
D
Common Stock
2024-03-08
4
M
0
2020
0.0
A
15665
D
Common Stock
2024-03-08
4
F
0
894
104.52
D
14771
D
Common Stock
0.0
2024-03-07
4
M
0
966
0.0
D
2023-03-07
2025-03-07
Common Stock
966
966
D
Common Stock
2024-03-08
4
A
0
6459
0.0
A
Common Stock
6459
6459
D
Performance Shares
0.0
2024-03-07
4
M
0
5792
0.0
D
2024-03-07
Common Stock
5792
0
D
Performance Shares
0.0
2024-03-08
4
M
0
2020
0.0
D
2023-03-08
2024-03-08
Common Stock
2020
0
D
These securities are Restricted Stock Units.
These Securities are Performance-based Restricted Stock Units (PRSU).
There is neither a purchase price nor an exercise price for the Restricted Stock Units.
One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
These are restricted stock units that fully vest 3 years from the grant date.
There is neither a purchase price nor an exercise price for the PRSUs.
These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.
By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
2024-03-11